Navigation Links
Children's Hospital of Philadelphia receives federal grant to improve health care decision-making
Date:1/14/2013

The Children's Hospital of Philadelphia (CHOP) was awarded nearly $2M in research funding from the Patient-Centered Outcomes Research Institute (PCORI) to study antibiotic delivery to children returning home after hospitalization for a severe bacterial infection.

The CHOP research is one of 25 projects totaling $40.7M selected from a pool of 500 applicants by PCORI's Board of Governors following a competitive, multi-stage review process involving scientists, patients, caregivers and other stakeholders. Proposals were evaluated on the basis of scientific merit, engagement of patients and stakeholders, methodological rigor and fit within PCORI's National Priorities for Research and Research Agenda.

When a child hospitalized with a serious bacterial infection is discharged, clinicians have two options: (1) transition from the intravenous antibiotics used in the hospital to a prolonged course of oral antibiotics at home; or (2) insert a central venous catheter (PICC) into a large vein in the chest and train the parents in care of the PICC and administration of intravenous antibiotics at home. "These two antibiotic treatment options have major implications for the overall experience of the child, families and caregivers, but there is a lack of real-world evidence on their benefits and drawbacks to help clinicians and patient families make an informed choice," said Ron Keren, MD, MPH, who is leading the study and also directs the Center for Pediatric Clinical Effectiveness (CPCE) at CHOP. "If we find that the prolonged IV option is no better than the oral route, we think that most families would prefer for their child to take oral antibiotics."

In addition to studying the risks and benefits to each treatment choice, the research team will also include parent-investigators, who will inform the research questions being asked and advise the team on how best to communicate the pros and cons of each treatment option to parents.

"
'/>"/>

Contact: Dana Mortensen
mortensen@email.chop.edu
267-426-6092
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Hydrogen peroxide vapor enhances hospital disinfection of superbugs
2. Worries about dementia how hospitalization affects the elderly
3. Rhode Island Hospital: Adult entertainment workers likely to benefit from health care intervention
4. RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
5. BGI and the Childrens Hospital of Philadelphia launch the 1,000 Rare Diseases Project
6. How alert hospital employees improved hospitals MSRA infection rate
7. $500,000 Gruber Foundation Genetics Prize goes to Philadelphia scientist
8. Bloomberg School receives $28 million for family planning advocacy
9. UC Riverside turfgrass specialist receives high honor
10. University of Illinois receives grant to study ozone resistance in corn
11. CU-led team receives $9.2 million DOE grant to engineer E. coli into biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... of sunscreen and seawater signals a relaxing trip to ... idyllic beach vacation comes with an environmental hitch. When ... sea, they can become toxic to some of the ... many other marine animals. Their study appears in the ... Antonio Tovar-Sanchez and David Snchez-Quiles point out that other ...
(Date:8/20/2014)... bags could one day be made out of cocoa, ... now reporting. The novel process they developed and their ... agricultural and plastic waste problems, appear in the ACS ... Bayer and colleagues at the Italian Institute of Technology ... 2012, its production reached 288 million tons worldwide, but ...
(Date:8/20/2014)... to about 4,000 members, it triggers an important first ... special type of comb used for rearing male reproductive, ... of Neurobiology and Behaviour at Cornell University, led by ... honeybee colonies. The results are published in Springer,s journal ... , Reproduction isn,t always a honeybee colony,s top priority. ...
Breaking Biology News(10 mins):Worker bees 'know' when to invest in their reproductive future 2
... time, researchers at the UCLA Henry Samueli School of ... its limits by genetically modifying Escherichia coli , ... unusually long-chain alcohols essential in the creation of biofuels. ... synthesize long-chain alcohols containing five carbon atoms," said James ...
... your time among stores, restaurants and skyscrapers, it may be ... A new study in Psychological Science , a journal ... in nature may be more beneficial for mental processes than ... Jonides, and Stephen Kaplan from the University of Michigan designed ...
... and make way for a "green" holiday. Here are ... environmentally friendly, courtesy of the American Chemical Society (ACS), ... Chemistry Institute. The Institute works to foster the discovery ... generation and use of hazardous substances. ,To reduce your ...
Cached Biology News:Researchers push nature beyond its limits to create higher-density biofuels 2
(Date:8/20/2014)... 20, 2014 /PRNewswire-iReach/ -- A case study from ... the school,s bioengineering department and the Intel® Internet ... Software Academic Program, UCSD,s research focuses on exploring ... body.  Photo - http://photos.prnewswire.com/prnh/20140819/137540 ... work of Dr. Todd P. Coleman , ...
(Date:8/19/2014)... Shimadzu Scientific Instruments has introduced ... Nexera-i, adding to the company’s extensive line-up of ... intuitive operating environment, and full automation, the i-Series ... for conventional to ultra-high-speed analysis. , ... design so users can begin building the lab ...
(Date:8/19/2014)... CA (PRWEB) August 19, 2014 Robin ... Parkinson’s disease can take on an individual. Symptoms ... decreased facial expression, problems swallowing and severe depression. ... the dying off of dopamine producing neurons of the ... from a disease that slowly and progressively gets worse, ...
(Date:8/19/2014)... 19, 2014   Synthetic Biologics, Inc. ... anti-infective biologic and drug programs targeting specific pathogens ... that its novel C. difficile development ... Interscience Conference on Antimicrobial Agents and Chemotherapy ... Synthetic Biologics, Senior Vice ...
Breaking Biology Technology:Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4
... colon, and ... prostate cancers-, TORONTO, Oct. ... and developing the next wave of,antibody therapeutics, today announced that the ... completed its first,toxicology study and has shown good efficacy in animal ...
... Wrong Should be put ... Stefano, ROME, October 23 Giovanni Di Stefano has called ... In,a letter supported by Dr John Trestrail who researched the flawed,conviction ... for,the pardon to be ,effective forthwith notwithstanding the passage of time.,Other ...
... ON, Oct. 22 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... oncology company that identifies,develops and commercializes differentiated products ... Directors has adopted a renewed,Shareholder Rights Plan Agreement. ... treatment of shareholders in connection with any take-over ...
Cached Biology Technology:ARIUS announces cancer stem cell antibody program successfully completes first toxicology study 2ARIUS announces cancer stem cell antibody program successfully completes first toxicology study 3YM Biosciences announces adoption of renewed Shareholders' Rights Plan 2YM Biosciences announces adoption of renewed Shareholders' Rights Plan 3
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Anti Human S14G-Humanin Polyclonal Antibody...
... familiar interface for data capture, recording, ... transition from paper to this powerful ... contains an integrated LIMS, notary service, ... These functions allow LABTrack to achieve ...
High voltage electrophoresis power supply...
Biology Products: